Your browser doesn't support javascript.
loading
Three Cases of Sertoli-Leydig Cell Tumor / 대한산부인과학회지
Korean Journal of Obstetrics and Gynecology ; : 682-689, 2006.
Article in Korean | WPRIM | ID: wpr-30493
ABSTRACT
Sertoli-Leydig cell tumors of the ovary are one of the sex cord-stromal tumors. They are very rare, account for less than 0.5% of all ovarian tumor. These tumors are almost unilateral, and occur predominantly at premenopausal state and rarely at postmenopausal and prepubertal. The most specific symptoms are virilization due to hyperandrogenism but it presents only in 40-50% of the patients, and vast majority of the patients complain for non-specific abdominal symptoms and menstrual disorder including vaginal bleeding. Prognosis and treatment modalities for Sertoli-Leydig cell tumors remain controversial as they are rare and only a few studies have been published. Treatment varies with patients age, tumor stage, and differentiation from unilateral salpingo-oophrectomy and total hysterectomy concomitant with pelvic lymph node dissection, and in occasion, adjuvant chemotherapy. Prognosis is generally favorable with 5-year survival rate of 70-90%. Recurrence is rare. We have experienced three cases of Sertoli-Leydig cell tumor, each of them showed different clinical presentation and histologic findings, so we present them with a brief review of literature.
Subject(s)

Full text: Available Index: WPRIM (Western Pacific) Main subject: Ovary / Prognosis / Recurrence / Uterine Hemorrhage / Virilism / Survival Rate / Chemotherapy, Adjuvant / Sex Cord-Gonadal Stromal Tumors / Sertoli-Leydig Cell Tumor / Hyperandrogenism Type of study: Prognostic study Limits: Female / Humans Language: Korean Journal: Korean Journal of Obstetrics and Gynecology Year: 2006 Type: Article

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: WPRIM (Western Pacific) Main subject: Ovary / Prognosis / Recurrence / Uterine Hemorrhage / Virilism / Survival Rate / Chemotherapy, Adjuvant / Sex Cord-Gonadal Stromal Tumors / Sertoli-Leydig Cell Tumor / Hyperandrogenism Type of study: Prognostic study Limits: Female / Humans Language: Korean Journal: Korean Journal of Obstetrics and Gynecology Year: 2006 Type: Article